Congratulations, Dr. Meehan, on your Excellence in Teaching Award! NNECOS Board Member, Dr. Ken Meehan, center, pictured with Fellow Board Liaison Dr. Odeth Barrett-Campbell and Fellow Dr. Lukas Emery.

Register for the series today and be sure to sign up for NNECOS sponsored lunch!

Sign up for the monthly series today. Continuing Nursing Education available for some sessions! 

• Northern Light Health - Physician Medical Director -Oncology Service Line
• UVM Cancer Center / Larner College of Medicine 
• Academic clinician with experience in lung cancer, melanoma and immunotherapy - Assistant or Associate Professor in the Clinical Scholars Pathway
• Physician-scientist/academic clinician with experience in breast cancer - Associate Professor or Full Professor in the Clinical Scholar Pathway
• Classical hematologist - Assistant Professor, Associate Professor, or Professor in the Clinical Scholar Pathway
• DHMC Norris Cotton Cancer Center - oncologist positions at Dartmouth-Hitchcock Keene / Cheshire Medical Center, Dartmouth-Hitchcock Manchester & Concord, and Southwestern Vermont Regional Cancer Center

•  Northern Light Health Eastern Maine Medical Center - Clinical Research Nurse
• Northern Light Health Eastern Maine Medical Center - Board-certified/board eligible hematologist/oncologist
• New England Cancer Specialists - multiple positions

Please read this special message to our community.

Latest FDA Approvals

• June 22nd - FDA grants accelerated approval to dabrafenib in combination with trametinib for unresectable or metastatic solid tumors with BRAF V600E mutation
• May 27th - FDA approves tisagenlecleucel for relapsed or refractory follicular lymphoma
• May 27th - FDA approves Opdivo in combination with chemotherapy and Opdivo in combination with Yervoy for first-line esophageal squamous cell carcinoma indications
• May 25th - FDA approves ivosidenib in combination with azacitidine for newly diagnosed acute myeloid leukemia
• May 20th - FDA approves azacitidine for newly diagnosed juvenile myelomonocytic leukemia

Other Updates

• Amgen Health Equity Summit - April 21st
• Pyruvate Kinase Deficiency: Clinical Manifestations and a New Treatment Option - May 9th
  

ASCO Survey on COVID in Oncology Registry

The aim is to help the cancer community learn more about the patterns of symptoms & severity of COVID among patients with cancer, as well as the impact on delivery of cancer care & patient outcomes. Periodic reports will deliver real-time information to the oncology community.

• ASCO Registry FAQs
• Enroll Your Practice
• Questions

ASCO COVID Resource Page

COVID Info & Resources including a Fact Sheet on EUA of BAmlanivimab